You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
|
---|---|
Published in |
Pharmacological Reports, March 2009
|
DOI | 10.1016/s1734-1140(09)70024-6 |
Pubmed ID | |
Authors |
Jarogniew J. Łuszczki |
Abstract |
This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug interactions of novel (third-generation) antiepileptic drugs, including brivaracetam, carabersat, carisbamate, DP-valproic acid, eslicarbazepine, fluorofelbamate, fosphenytoin, ganaxolone, lacosamide, losigamone, pregabalin, remacemide, retigabine, rufinamide, safinamide, seletracetam, soretolide, stiripentol, talampanel, and valrocemide. These novel antiepileptic drugs undergo intensive clinical investigations to assess their efficacy and usefulness in the treatment of patients with refractory epilepsy. |
Mendeley readers
The data shown below were compiled from readership statistics for 192 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 2 | 1% |
Germany | 1 | <1% |
Korea, Republic of | 1 | <1% |
Sweden | 1 | <1% |
South Africa | 1 | <1% |
Argentina | 1 | <1% |
Romania | 1 | <1% |
China | 1 | <1% |
Spain | 1 | <1% |
Other | 2 | 1% |
Unknown | 180 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 29 | 15% |
Researcher | 23 | 12% |
Student > Master | 18 | 9% |
Student > Doctoral Student | 16 | 8% |
Student > Bachelor | 16 | 8% |
Other | 48 | 25% |
Unknown | 42 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 46 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 29 | 15% |
Agricultural and Biological Sciences | 21 | 11% |
Neuroscience | 14 | 7% |
Chemistry | 14 | 7% |
Other | 24 | 13% |
Unknown | 44 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2023.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Pharmacological Reports
#241
of 943 outputs
Outputs of similar age
#38,547
of 108,601 outputs
Outputs of similar age from Pharmacological Reports
#2
of 3 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 943 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,601 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.